Copyright

Additional Metadata
Keywords adalimumab, anti-TNF antibody, height velocity z-score, linear growth, pediatric Crohn's disease
Persistent URL dx.doi.org/10.1097/MIB.0000000000001075, hdl.handle.net/1765/100145
Journal Inflammatory Bowel Diseases
Citation
Walters, T.D. (Thomas D.), Faubion, W.A. (William A.), Griffiths, A, Baldassano, R.N, Escher, J.C, Ruemmele, F.M, … Thakkar, R.B. (Roopal B.). (2017). Growth Improvement with Adalimumab Treatment in Children with Moderately to Severely Active Crohn's Disease. Inflammatory Bowel Diseases, 23(6), 967–975. doi:10.1097/MIB.0000000000001075